Correlation Between BeiGene and Blueprint Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BeiGene and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and Blueprint Medicines Corp, you can compare the effects of market volatilities on BeiGene and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Blueprint Medicines.

Diversification Opportunities for BeiGene and Blueprint Medicines

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between BeiGene and Blueprint is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of BeiGene i.e., BeiGene and Blueprint Medicines go up and down completely randomly.

Pair Corralation between BeiGene and Blueprint Medicines

Given the investment horizon of 90 days BeiGene is expected to under-perform the Blueprint Medicines. But the stock apears to be less risky and, when comparing its historical volatility, BeiGene is 1.55 times less risky than Blueprint Medicines. The stock trades about -0.29 of its potential returns per unit of risk. The Blueprint Medicines Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  8,277  in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of  1,110  from holding Blueprint Medicines Corp or generate 13.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BeiGene  vs.  Blueprint Medicines Corp

 Performance 
       Timeline  
BeiGene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BeiGene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BeiGene is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Blueprint Medicines Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, Blueprint Medicines is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

BeiGene and Blueprint Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BeiGene and Blueprint Medicines

The main advantage of trading using opposite BeiGene and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.
The idea behind BeiGene and Blueprint Medicines Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format